The primary focus of Syngene as a CRO is in helping pharma and biopharma industries and address recent complex drug development challenges and improve considerably in the coming few years. Clients advanced to engage in CROs to provide data-driven insights and drive the changing drug development forum for the next generation of medicines and biological practices. In general for that research and developing a drug or product and acquiring the regulatory approval from the concerned FDA used to be the ultimate target. But nowadays, there are several challenges emerged in addition to the routine set of objectives. Such as challenge of procuring reimbursement and tapping the market, additional cost and complexity to the drug development process in the advanced technology world. Commitment in retaining for clinical trials and lab services, drive the clients to seek data and analytics for trial insights and design thinking, drug development planning, medical affairs and regulatory consulting from CROs in the real time basis. This is one side of the challenges. The other side includes, demands for safety in the work place and pharmacovigilance, clinical trial feasibility, consistency, protocol optimization, and real-world evidence.
In the view of the current challenges, the practice of drug research, clinical trials and the how data getting generated and analysis is consistently changing. There are several trends in the organization in especially in the chemical and bio chemical operations to leverage the advanced technology with respect to the advancement in drug research. The initiations like increased focusing on the virtual trails and novel technology techniques and sample collection tools to access and interpret the data in the more realistic.
The advancement of leverage IT in Syngene deliberately improves the current challenges in the real world scenarios. Intelligent data capture software is one of the practices implemented recently in the better quality of the data analysis in clinical trials. This overcomes the issues like trail management, data visibility and forecast in the clinical research and ultimate mitigation of the emergent challenges. The information technology initiatives improve the quality of the process and standardized and centralized the platform. The technology had always helped the industry to automate its process than the manual. Technology also played a prominent role in the post approval process. The clients want assurance that the perceived value of the product justified in a well controlled analytical support and clinical trials. This increases the possible to leverage the several data in to the real world. The technology implementation drives to much more than the past and it diver with speed in the real world competition. Over- engineered their technology in the organization is adding the cost and complexity. In order to a successful pioneer in the technology adopter in the Pharma, Syngene took few deliberate steps as which technology fit in the organization, connectivity, workflow and culture. The advantages in the technology can be acquired by upgrade to the advanced technology in the all aspects of the chemistry and biology to establish in the global market. In the view of the recent challenges, organization must be committed to advance the speed in the innovation and process development. Discovery in technology, operating tools and process are the required components of the prospect future business. The innovation in the advanced technology primarily focused on rapid data integration, advanced analytical facilities, taking advantage of disruptive innovation and taking the operational excellence and continuous improvement in core operations.